ОRAL SIGNS AND SYMPTOMS IN COVID-19

Authors

  • Mihajlo Petrovski Faculty of medical sciences, Goce Delcev University, Stip, Republic of North Macedonia
  • Kiro Papakoca Faculty of medical sciences, Goce Delcev University, Stip, Republic of North Macedonia

Keywords:

COVID-19, oral signs, oral symptoms, SARS-CoV-2

Abstract

The clinical symptoms of COVID-19 infection are not fully described, and most of them are still documented and collecting.The disease is characterized with a numerous clinical signs and symptoms predominant of the respiratory system, including dry cough, which is usually accompanied by fever, difficulties in breathing, and adynamia, but also other less typical symptoms of infectious disease have been described . The cause of this disease is present in both the oral cavity and saliva, which means that the environment in which we work is an excellent reservoir of viral microorganisms. As mentioned, in patients with COVID-19 the most common symptoms are occurrence of fever (more than 38 ° C), cough, shortness of breath, myalgia, rhinorrhea, sore throat, anosmia and aggeusia (the last two symptoms are most often associated with this infection). Given the fact that patients with COVID-19 may have oral signs and symptoms, there is a need for research that will note the most common oral signs and symptoms in these individuals. Hence, the main goal of the research was to make aadequate literary review of the most common oral signs and symptoms in people with COVID-19. For the realization of the main goal, a literary review was made using the following keywords "COVID-19", "SARS-CoV-2", "coronavirus-19", "oral health", "oral changes" and "oral lessions" . Scientific data published exclusively in English, in professional and scientific journals from the last three years (2019, 2020 and 2021) were used. Although at the beginning of the COVID-19 pandemic, it was believed that this infection would have no effect on oral health, nowadays it is known that have an impact on oral structures. Inadequate oral hygiene, the occurrence of opportunistic infections, stress, the presence of additional systemic diseases (diabetes mellitus, immunosuppression, etc.), trauma (as a consequence of intubation), vascular influences and hyperinflammatory reaction that occurs secondary, are the most important predisposing factors for the development of oral lesions in positive COVID - 19 patients. Based on the literature data, it can be noted that in patients with COVID-19 can be noted numerous orofacial signs which may help clinicians to identify suspicious cases. These changes are most commonly manifested- oral ulcers, erithematous macules, vesicular-bullous lesions and acute inflammation of the parotid gland. However, the fact presented in the modern literature that oral manifestations are rarely reported, due to the lack of dental examinations of patients with COVID-19 (insufficient attention paid to not so serious oral signs and symptoms compared to typical clinical manifestations). We believe that further studies are needed using large groups of COVID-19 patients to document all orofacial manifestations associated with COVID-19. Dentists should play a key role in the fight against KOVID-19 by recognizing oral manifestations, and before the appearance of the first systemic signs and symptoms of the disease. Therefore, dentists should be familiar with all potential orofacial manifestations of COVID-19.

References

Ansari, R., Gheitani, M., & Heidari, F. (2020). Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor. Oral Diseases.

Brandini, D. A., Takamiya, A. S., Thakkar, P., Schaller, S., Rahat, R., & Naqvi, A. R. (2021). Covid‐19 and oral diseases: Crosstalk, synergy or association?. Reviews in Medical Virology.

Capaccio, P., Pignataro, L., Corbellino, M., Popescu-Dutruit, S., & Torretta, S. (2020). Acute parotitis: a possible precocious clinical manifestation of SARS-CoV-2 infection?. Otolaryngology–Head and Neck Surgery, 163(1), 182-183.

Chaux-Bodard, A. G., Deneuve, S., & Desoutter, A. (2020). Oral manifestation of Covid-19 as an inaugural symptom?. Journal of Oral Medicine and Oral Surgery, 26(2), 18.

Chen, L., Zhao, J., Peng, J., Li, X., Deng, X., Geng, Z., ... & Wang, S. (2020). Detection of SARS‐CoV‐2 in saliva and characterization of oral symptoms in COVID‐19 patients. Cell proliferation, 53(12), e12923.

Ciccarese, G., Drago, F., Boatti, M., Porro, A., Muzic, S. I., & Parodi, A. (2020). Oral erosions and petechiae during SARS‐CoV‐2 infection. Journal of medical virology.

Dos Santos, J. A., Normando, A. G. C., da Silva, R. L. C., De Paula, R. M., Cembranel, A. C., Santos-Silva, A. R., & Guerra, E. N. S. (2020). Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?. International Journal of Infectious Diseases, 97, 326-328.

Dziedzic, A., & Wojtyczka, R. (2021). The impact of coronavirus infectious disease 19 (COVID‐19) on oral health. Oral diseases, 27, 703-706.

Fini, M. B. (2020). What dentists need to know about COVID-19. Oral oncology, 105, 104741.

Fisher, J., Monette, D. L., Patel, K. R., Kelley, B. P., & Kennedy, M. (2021). COVID-19 associated parotitis. The American Journal of Emergency Medicine, 39, 254-e1.

Halboub, E., Al-Maweri, S. A., Alanazi, R. H., Qaid, N. M., & Abdulrab, S. (2020). Orofacial manifestations of COVID-19: a brief review of the published literature. Brazilian Oral Research, 34, e124-e124.

Jimenez‐Cauhe, J., Ortega‐Quijano, D., Carretero‐Barrio, I., Suarez‐Valle, A., Saceda‐Corralo, D., Del Real, C. M. G., & Fernandez‐Nieto, D. (2020). Erythema multiforme‐like eruption in patients with COVID‐19 infection: clinical and histological findings. Clinical and experimental dermatology.

Kahraman, F. C., & Çaşkurlu, H. (2020). Mucosal involvement in a COVID‐19‐positive patient: a case report. Dermatologic therapy.

Labé, P., Ly, A., Sin, C., Nasser, M., Chapelon‐Fromont, E., Saïd, P. B., & Mahé, E. (2020). Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children. Journal of the European Academy of Dermatology and Venereology.

Lechien, J. R., Chetrit, A., Chekkoury-Idrissi, Y., Distinguin, L., Circiu, M., Saussez, S. & Carlier, R. (2020). Early Release-Parotitis-Like Symptoms Associated with COVID-19, France

López-Sánchez, A. F., Jané-Salas, E., & ML, S. P. (2020). Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Diseases.

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J.( 2020). HLH Across Speciality Collaboration, UK COVID-19: Consider cytokine storm syndromes and immunosuppression [published online ahead of print, 2020 Mar 16]. The Lancet, 395, 1033–1034.

Patel, J., & Woolley, J. (2021), Necrotizing periodontal disease: Oral manifestation of COVID-19. Oral Dis, 27: 768-769.

Ramírez‐Amador, V., Zambrano, J. G., Anaya‐Saavedra, G., Zentella‐Dehesa, A., Irigoyen‐Camacho, E., Meráz‐Cruz, N., & Ponce de León‐Rosales, S. (2017). TNF as marker of oral candidiasis, HSV infection, and mucositis onset during chemotherapy in leukemia patients. Oral diseases, 23(7), 941-948.

Rodríguez, M. D., Romera, A. J., & Villarroel, M. (2020). Oral manifestations associated with COVID‐19. Oral diseases.

To, K. K. W., Chan, K. H., Ho, J., Pang, P. K. P., Ho, D. T. Y., Chang, A. C. H. & Yuen, K. Y. (2019). Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study. Clinical Microbiology and Infection, 25(12), 1539-1545.

Wang, W. K., Chen, S. Y., Liu, I. J., Chen, Y. C., Chen, H. L., Yang, C. F.& Chang, S. C. (2004). Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerging infectious diseases, 10(7), 1213.

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., & Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine, e200994

Downloads

Published

2022-02-18

How to Cite

Petrovski, M., & Papakoca, K. (2022). ОRAL SIGNS AND SYMPTOMS IN COVID-19. KNOWLEDGE - International Journal , 50(4), 427–430. Retrieved from https://ikm.mk/ojs/index.php/kij/article/view/4948

Most read articles by the same author(s)

1 2 3 > >>